Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to tegoprubart for the prevention of ...

We previously described restrictive allograft syndrome as a form of chronic lung allograft dysfunction, demonstrating restrictive pulmonary function decline. However, the histopathological correlates ...

Phase II study of RCHOP with pegylated liposomal doxorubicin (DRCOP) for patients older than age 60 with untreated diffuse large B-cell lymphoma (DLBCL). This is an ASCO Meeting Abstract from the 2011 ...

IRVINE, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (ELDN) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to ...

Please provide your email address to receive an email when new articles are posted on . Proximal humeral bone loss is commonly encountered in the arthroplasty setting and this can provide a ...

VIRGINIA BEACH, Va., Feb. 15, 2025 /PRNewswire/ -- LifeNet Health proudly announces the launch of OraGen®, the first viable dental bone allograft comprised of cryopreserved corticocancellous bone ...

Obstruction of the airway causes substantial morbidity, and with the increased use of artificial airways, the incidence of tracheal stenosis is increasing. A tracheal defect that is shorter than 5 cm ...

Recurrent glomerulonephritis is a known cause of renal allograft loss; however, the incidence of this complication is poorly defined. We determined the incidence, timing, and relative importance of ...

“Integra LifeSciences is dedicated to the development of innovative regenerative technologies to treat soft tissue wounds and help heal patients. We are excited to now offer clinicians an amniotic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Allograft failure risk decreased in patients at 34 years ...